“遏制商业贿赂”与“去行政化”才是药品(疫苗)市场回归有序的当务之急——从《我不是药神》到“长生公司疫苗案”引发的法律漫谈

Curbing commercial bribery and de-administration are the most urgent tasks for the return of drug and vaccine markets to order——A chat from DyingTo Survive to Longevity Vaccine Cases

我国药品市场的问题颇多,药品质量不稳定、药价居高不下、患者可及性不好等等。如果要解决这些表面现象,作者认为必须改变政府主管部门行政监管的重心,首先把"遏制商业贿赂"与"去行政化"作为药品和疫苗市场回归有序的当务之急;其次开放"针对慢病患者的互联网处方药品交易"以及"将进口原研处方药引入跨境电商正面清单"。

China＇s drug market has many problems, such as unstable drug quality, high drug prices, poor accessibility of patients and so on. If you want to solve the phenomenon, the author thinks that must change the key point of government for administrative supervision. Firstly, ＂curbing commercial bribery＂ and ＂de-administration＂ is the drugs market return order. The second is to permit Internet trading of prescription drugs for chronic diseases, and add Imported prescription drugs to the positive list of cross-border e-commerce.